Compensation 990
OrganizationsEmployeesBoard MembersGrantsContractorsTop RankingsPricing

Stay updated on 990 organization compensation

© Civic Register LLC

Compensation 990 is an independent service that uses public IRS Form 990 filings as its source data. We clean and standardize this information, but the original filings may contain errors or omissions. Years on this site refer to the organization’s fiscal year end date on the filing.

About•Report a discrepancy•Your privacy choices
Organizations Science & Technology Research Cystic Fibrosis Foundation Therapeutics Inc.

Cystic Fibrosis Foundation Therapeutics Inc.

Fiscal year ending 2017. Filed on October 2, 2018.

4550 Montgomery Avenue Suite 1100n
3333 Burnet Avenue
Bethesda, Maryland 20814

Cystic Fibrosis Foundation Therapeutics Inc. (EIN: 91-2059167) has filed an IRS Form 990 between fiscal years 2016 and 2024. In its fiscal year 2017 IRS Form 990 filing, Cystic Fibrosis Foundation Therapeutics Inc., a 501(c)(3) charitable organization, reported compensation for 13 out of 61 total employees. Among the employees shown here, the average compensation is $492,188. The highest compensated employee at Cystic Fibrosis Foundation Therapeutics Inc. is Preston Campbell, M.D. with fiscal year 2017 compensation of $1,409,782.

Revenue, expenses, and employee compensation

Revenue

$125,014,560

Expenses

$125,014,560

Employee compensation

$10,480,531
Revenue, expenses, and employee compensation over time

Reported Compensated Employees

Preston Campbell, M.D.
President and Chief Executive Officer
$1,409,782
$396,810 $805,765 $207,207
Marc S Ginsky
Executive Vice President, COO and Secretary
$889,224
$0 $663,211 $226,013
Vera H Twigg
Executive Vice President and Chief Financial Officer
$652,456
$0 $524,706 $127,750
Michael P Boyle, M.D.
Senior Vice President, Therapeutics DEV
$567,634
$503,945 No related comp$63,689
Bruce C Marshall, M.D.
Senior Vice President of Clinical Affairs
$564,279
$101,381 $430,358 $32,540
William Skach, M.D.
Senior Vice President , Research Affairs
$563,157
$421,375 $74,361 $67,421
Robert J Beall, Ph.D.
Former Chief Executive Officer
$439,043
$55,949 $383,094 No other comp
Martin Mense, Ph.D.
Vice President of DRUG Discovery
$320,252
$253,980 No related comp$66,272
Jerome Mahiou, Ph.D.
Senior Scientist
$202,317
$153,337 No related comp$48,980
Feng Liang, Ph.D.
Senior Scientist
$202,247
$154,775 No related comp$47,472
Hermann Bihler, Ph.D.
Fellow Scientist
$200,014
$181,398 No related comp$18,616
C Richard Mattingly
Former Chief Operating Officer
$197,010
$0 $197,010 No other comp

Benchmark Employee Compensation

Non-Employee Board Members

Carole B Griego, M.D.
Director
Catherine C McLoud
Director
D Paul Flessner
Director
Eric R Olson, Ph.D.
Director
Jason M Aryeh
Director
Jonathan Cohn, M.D.
Director
Steven Shak, M.D.
Director
Theodore J Torphy, Ph.D.
Chair

Contractors

Vertex Pharmaceuticals Inc.
Contracted Research
$12,500,000
Genzyme Corporation
Contracted Research
$9,330,280
Pfizer Inc.
Contracted Research
$2,120,889
Celtaxsys Inc.
Contracted Research
$2,073,333
Spyryx Biosciences Inc.
Contracted Research
$2,023,217

Mission Statement

THE MISSION IS TO CURE CYSTIC FIBROSIS AND TO PROVIDE ALL PEOPLE WITH CF THE OPPORTUNITY TO LEAD LONG, FULFILLING LIVES.

Revisions to this organization profile

November 14, 2025:
2024 Cystic Fibrosis Foundation Therapeutics Inc. 990 filed
November 12, 2024:
2023 Cystic Fibrosis Foundation Therapeutics Inc. 990 filed
November 14, 2023:
2022 Cystic Fibrosis Foundation Therapeutics Inc. 990 filed

Get an email when new compensation information is released for Cystic Fibrosis Foundation Therapeutics Inc.

Be the first to know when new IRS Form 990 data is published for this organization.

Related Jobs

View more jobs
Powered by Talroo
Report a discrepancy →